BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 29108783)

  • 21. Time-series analysis to observe the impact of a centrally organized educational intervention on the prevention of central-line-associated bloodstream infections in 32 German intensive care units.
    Hansen S; Schwab F; Schneider S; Sohr D; Gastmeier P; Geffers C
    J Hosp Infect; 2014 Aug; 87(4):220-6. PubMed ID: 24973015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of state legal mandates for data submission of central line-associated bloodstream infections in neonatal intensive care units with process and outcome measures.
    Zachariah P; Reagan J; Furuya EY; Dick A; Liu H; Herzig CT; Pogorzelska-Maziarz M; Stone PW; Saiman L
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1133-9. PubMed ID: 25111921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey.
    Ben-David D; Vaturi A; Solter E; Temkin E; Carmeli Y; Schwaber MJ;
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1094-1099. PubMed ID: 31339089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of International Nosocomial Infection Control Consortium (INICC) strategy on central line-associated bloodstream infection rates in the intensive care units of 15 developing countries.
    Rosenthal VD; Maki DG; Rodrigues C; Alvarez-Moreno C; Leblebicioglu H; Sobreyra-Oropeza M; Berba R; Madani N; Medeiros EA; Cuéllar LE; Mitrev Z; Dueñas L; Guanche-Garcell H; Mapp T; Kanj SS; Fernández-Hidalgo R;
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1264-72. PubMed ID: 21029008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreasing Central Line-associated Bloodstream Infections Through Quality Improvement Initiative.
    Balla KC; Rao SP; Arul C; Shashidhar A; Prashantha YN; Nagaraj S; Suresh G
    Indian Pediatr; 2018 Sep; 55(9):753-756. PubMed ID: 30345978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of infection control cost reimbursement policy on central line-associated bloodstream infections.
    Park JY; Kwon KT; Lee WK; Kim HI; Kim MJ; Song DY; Yu MH; Park HJ; Lee KH; Chae HJ
    Am J Infect Control; 2020 May; 48(5):560-565. PubMed ID: 31677923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten-year surveillance of central line-associated bloodstream infections in South Korea: Surveillance not enough, action needed.
    Kim EJ; Kang SY; Kwak YG; Kim SR; Shin MJ; Yoo HM; Han SH; Kim DW; Choi YH;
    Am J Infect Control; 2020 Mar; 48(3):285-289. PubMed ID: 31493935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hospital-wide reduction in central line-associated bloodstream infections through systematic quality improvement initiative and multidisciplinary teamwork.
    Han J; Wan J; Cheng Y; Li D; Deng M; Wang X; Feng J; He Y; Ye Q; Wang L; Lei Y; Wang J
    Am J Infect Control; 2019 Nov; 47(11):1358-1364. PubMed ID: 31277999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepwise introduction of the 'Best Care Always' central-line-associated bloodstream infection prevention bundle in a network of South African hospitals.
    Richards GA; Brink AJ; Messina AP; Feldman C; Swart K; van den Bergh D;
    J Hosp Infect; 2017 Sep; 97(1):86-92. PubMed ID: 28549778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradicating central line-associated bloodstream infections statewide: the Hawaii experience.
    Lin DM; Weeks K; Bauer L; Combes JR; George CT; Goeschel CA; Lubomski LH; Mathews SC; Sawyer MD; Thompson DA; Watson SR; Winters BD; Marsteller JA; Berenholtz SM; Pronovost PJ; Pham JC
    Am J Med Qual; 2012; 27(2):124-9. PubMed ID: 21918016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of central venous catheter bundle in an intensive care unit in Kuwait: Effect on central line-associated bloodstream infections.
    Salama MF; Jamal W; Al Mousa H; Rotimi V
    J Infect Public Health; 2016; 9(1):34-41. PubMed ID: 26138518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a program to prevent central line-associated bloodstream infection in the zero tolerance era.
    Marra AR; Cal RG; Durão MS; Correa L; Guastelli LR; Moura DF; Edmond MB; Dos Santos OF
    Am J Infect Control; 2010 Aug; 38(6):434-9. PubMed ID: 20226570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of State Reporting Laws on Central Line-Associated Bloodstream Infection Rates in U.S. Adult Intensive Care Units.
    Liu H; Herzig CTA; Dick AW; Furuya EY; Larson E; Reagan J; Pogorzelska-Maziarz M; Stone PW
    Health Serv Res; 2017 Jun; 52(3):1079-1098. PubMed ID: 27451968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Central Line Care Maintenance Bundle for the Prevention of Central Line-Associated Bloodstream Infection in Non-Intensive Care Unit Settings.
    O'Neil C; Ball K; Wood H; McMullen K; Kremer P; Jafarzadeh SR; Fraser V; Warren D
    Infect Control Hosp Epidemiol; 2016 Jun; 37(6):692-8. PubMed ID: 26999746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to minimize central line-associated bloodstream infections in a neonatal intensive care unit: a quality improvement intervention based on a retrospective analysis and the adoption of an evidence-based bundle.
    Bierlaire S; Danhaive O; Carkeek K; Piersigilli F
    Eur J Pediatr; 2021 Feb; 180(2):449-460. PubMed ID: 33083900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the CUSP: Stop BSI: evaluating the relationship between central line-associated bloodstream infection rate and patient safety climate profile.
    Weaver SJ; Weeks K; Pham JC; Pronovost PJ
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S203-8. PubMed ID: 25239711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple educational intervention to decrease incidence of central line-associated bloodstream infection (CLABSI) in intensive care units with low baseline incidence of CLABSI.
    Pérez Parra A; Cruz Menárguez M; Pérez Granda MJ; Tomey MJ; Padilla B; Bouza E
    Infect Control Hosp Epidemiol; 2010 Sep; 31(9):964-7. PubMed ID: 20658936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.